Healthcare provider profile · identity verified

Julio Cesar Munoz, MD

Internal Medicine · CARLSBAD, NM · NPI 1598721433

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	499	137
Lisinopril	Lisinopril	445	118
Levothyroxine Sodium	Levothyroxine Sodium	426	84
Amlodipine Besylate	Amlodipine Besylate	370	89
Simvastatin	Simvastatin	331	93
Metformin Hcl	Metformin Hcl	307	84
Hydrochlorothiazide	Hydrochlorothiazide	301	74
Potassium Chloride	Potassium Chloride	295	73
Gabapentin	Gabapentin	275	71
Pantoprazole Sodium	Pantoprazole Sodium	243	70
Furosemide	Furosemide	240	64
Metoprolol Succinate	Metoprolol Succinate	237	58
Tamsulosin Hcl	Tamsulosin Hcl	215	54
Losartan Potassium	Losartan Potassium	209	53
Carvedilol	Carvedilol	195	50
Rosuvastatin Calcium	Rosuvastatin Calcium	186	50
Ozempic	Semaglutide	169	34
Pravastatin Sodium	Pravastatin Sodium	164	46
Omeprazole	Omeprazole	146	35
Sertraline Hcl	Sertraline Hcl	116	25
Albuterol Sulfate Hfa	Albuterol Sulfate	115	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	112	32
Metoprolol Tartrate	Metoprolol Tartrate	104	26
Escitalopram Oxalate	Escitalopram Oxalate	100	25
Synthroid	Levothyroxine Sodium	93	23
Allopurinol	Allopurinol	89	27
Fluticasone Propionate	Fluticasone Propionate	89	39
Clopidogrel	Clopidogrel Bisulfate	87	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	22
Glipizide	Glipizide	86	22
Famotidine	Famotidine	85	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	22
Ezetimibe	Ezetimibe	78	20
Spironolactone	Spironolactone	75	20
Trazodone Hcl	Trazodone Hcl	74	24
Tramadol Hcl	Tramadol Hcl	70	19
Folic Acid	Folic Acid	68	23
Xarelto	Rivaroxaban	66	11
Pregabalin	Pregabalin	64	16
Tizanidine Hcl	Tizanidine Hcl	64	27
Eliquis	Apixaban	61	17
Naproxen	Naproxen	61	28
Atenolol	Atenolol	56	13
Paroxetine Hcl	Paroxetine Hcl	52	12
Finasteride	Finasteride	51	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Celecoxib	Celecoxib	49	12
Warfarin Sodium	Warfarin Sodium	46	suppressed
Jardiance	Empagliflozin	42	11
Trulicity	Dulaglutide	42	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Memantine Hcl	Memantine Hcl	39	suppressed
Propranolol Hcl	Propranolol Hcl	37	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	36	11
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Glipizide Er	Glipizide	35	suppressed
Ibandronate Sodium	Ibandronate Sodium	35	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	32	suppressed
Lovastatin	Lovastatin	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Prednisone	Prednisone	28	15
Ibuprofen	Ibuprofen	27	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	18
Levetiracetam	Levetiracetam	25	suppressed
Azithromycin	Azithromycin	24	23
Donepezil Hcl	Donepezil Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Klor-Con M20	Potassium Chloride	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	21	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	11
Nifedipine Er	Nifedipine	20	suppressed
Sotalol	Sotalol Hcl	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Levofloxacin	Levofloxacin	18	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Novolog Flexpen	Insulin Aspart	13	11
Ursodiol	Ursodiol	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	11
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error